Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma

Vito W. Rebecca, Renato R. Massaro, Inna V. Fedorenko, Vernon K. Sondak, Alexander R.A. Anderson, Eunjung Kim, Ravi K. Amaravadi, Silvya S. Maria-Engler, Jane L. Messina, Geoffrey T. Gibney, Ragini R. Kudchadkar, Keiran S.M. Smalley

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds